Market Tracker

11/17 5:15pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

3.05
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
0.81
Today|||52-Week Range
3.68
+211.29%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.05
Today’s open2.95
Day’s range2.95 - 3.10
Volume416,006
Average volume (3 months)209,897
Market cap$108.7M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+33.55%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book32.88

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc0.000.00%
TRILTrillium Therapeutic...0.000.00%
VRMLVermillion Inc0.000.00%
IDXGInterpace Diagnostic...0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts